Global Protein Therapeutics Market Outlook 2020 - Players Investing Heavily in Multiple Sclerosis and Cancer Therapeutics
DUBLIN, Oct. 02 2015 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/td7mqg/global_protein) has announced the addition of the "Global Protein Therapeutics Market Outlook 2020" report to their offering.
Due to its increased usage, the market holds huge potential for future growth and it is estimated that by the end of 2020, it may reach the mark of US$ 208 Billion.
Furthermore, the launch of new products is also likely to propel the market growth.
According to our new research report, Global Protein Therapeutics Market Outlook 2020, a large number of existing and new market players are rigorously involved in developing monoclonal antibodies (mAbs). The mAbs segment accounts for the largest share in the current protein therapeutic products. The report, in this context, gives a comprehensive analysis of the current and future patterns of revenue generation with respect to mAbs and other segments, which includes insulin, EPO, interferon, G-CSF, human growth hormone , blood clotting factors and FSH.
The report takes into account all the important aspects of the global protein therapeutics market, and projects the market during the period 2013-2020. Some of the key aspects included in the report are the market share analysis of key players and the segmental analysis. The report also provides in depth analysis of various applications of the above mentioned protein therapeutics. The current as well as the future market prospects of the applications of major protein therapeutics is also provided in the report.
Through in-depth and careful analysis of the worldwide developments, we have observed that the US continues to hold a dominant position in the global protein therapeutics market, as the country provides a major proportion of the products' sales. However, our team of researchers has come up with an analysis that the future landscape looks promising, with respect to major contribution from emerging economies, which can be attributed to increasing awareness among people and an increased healthcare expenditure owing to the increase in the disposable income.
Key Topics Covered:
1. Analyst View
2. Research Methodology
3. Global Protein Therapeutics Market
4. Industry Performance
5. Advanced Phase Drugs Analysis
6. Emerging Market Trends
7. Porters Five Forces Analysis
8. Key Players
- Abbott Laboratories
- Amgen Inc.
- Biogen Idec Inc.
- Eli Lilly & Company
- Johnson & Johnson
- Merck Serono S.A.
- Novo Nordisk
- Pfizer
- Roche Group
- Sanofi-Aventis
For more information visit http://www.researchandmarkets.com/research/td7mqg/global_protein
Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net
Share this article